Search
Find a vulnerability
Search criteria
2 vulnerabilities found for life_sciences_empirica_signal by oracle
CVE-2026-21997 (GCVE-0-2026-21997)
Vulnerability from nvd – Published: 2026-04-21 20:34 – Updated: 2026-04-22 14:03
VLAI
EPSS
VEX
Summary
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Severity
8.5 (High)
SSVC
Exploitation: none
Automatable: no
Technical Impact: partial
CISA Coordinator (v2.0.3)
CWE
- Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.
- CWE-284 - Improper Access Control
Assigner
References
1 reference
| URL | Tags |
|---|---|
| https://www.oracle.com/security-alerts/cpuapr2026.html | vendor-advisory |
Impacted products
1 product
| Vendor | Product | Version | |
|---|---|---|---|
| Oracle Corporation | Oracle Life Sciences Empirica Signal |
Affected:
9.2.1 , ≤ 9.2.3
(custom)
|
{
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2026-21997",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "partial"
}
],
"role": "CISA Coordinator",
"timestamp": "2026-04-22T14:02:55.730217Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-284",
"description": "CWE-284 Improper Access Control",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2026-04-22T14:03:00.137Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"product": "Oracle Life Sciences Empirica Signal",
"vendor": "Oracle Corporation",
"versions": [
{
"lessThanOrEqual": "9.2.3",
"status": "affected",
"version": "9.2.1",
"versionType": "custom"
}
]
}
],
"cpeApplicability": [
{
"nodes": [
{
"cpeMatch": [
{
"criteria": "cpe:2.3:a:oracle:life_sciences_empirica_signal:*:*:*:*:*:*:*:*",
"versionEndIncluding": "9.2.3",
"versionStartIncluding": "9.2.1",
"vulnerable": true
}
],
"negate": false,
"operator": "OR"
}
]
}
],
"descriptions": [
{
"lang": "en-US",
"value": "Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N)."
}
],
"metrics": [
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "NONE",
"baseScore": 8.5,
"baseSeverity": "HIGH",
"confidentialityImpact": "LOW",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "CHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N",
"version": "3.1"
}
}
],
"problemTypes": [
{
"descriptions": [
{
"description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.",
"lang": "en-US"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2026-04-21T20:34:58.883Z",
"orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
"shortName": "oracle"
},
"references": [
{
"name": "Oracle Advisory",
"tags": [
"vendor-advisory"
],
"url": "https://www.oracle.com/security-alerts/cpuapr2026.html"
}
]
}
},
"cveMetadata": {
"assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
"assignerShortName": "oracle",
"cveId": "CVE-2026-21997",
"datePublished": "2026-04-21T20:34:58.883Z",
"dateReserved": "2026-01-05T18:07:34.723Z",
"dateUpdated": "2026-04-22T14:03:00.137Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.2"
}
CVE-2026-21997 (GCVE-0-2026-21997)
Vulnerability from cvelistv5 – Published: 2026-04-21 20:34 – Updated: 2026-04-22 14:03
VLAI
EPSS
VEX
Summary
Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).
Severity
8.5 (High)
SSVC
Exploitation: none
Automatable: no
Technical Impact: partial
CISA Coordinator (v2.0.3)
CWE
- Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.
- CWE-284 - Improper Access Control
Assigner
References
1 reference
| URL | Tags |
|---|---|
| https://www.oracle.com/security-alerts/cpuapr2026.html | vendor-advisory |
Impacted products
1 product
| Vendor | Product | Version | |
|---|---|---|---|
| Oracle Corporation | Oracle Life Sciences Empirica Signal |
Affected:
9.2.1 , ≤ 9.2.3
(custom)
|
{
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2026-21997",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "partial"
}
],
"role": "CISA Coordinator",
"timestamp": "2026-04-22T14:02:55.730217Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-284",
"description": "CWE-284 Improper Access Control",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2026-04-22T14:03:00.137Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"product": "Oracle Life Sciences Empirica Signal",
"vendor": "Oracle Corporation",
"versions": [
{
"lessThanOrEqual": "9.2.3",
"status": "affected",
"version": "9.2.1",
"versionType": "custom"
}
]
}
],
"cpeApplicability": [
{
"nodes": [
{
"cpeMatch": [
{
"criteria": "cpe:2.3:a:oracle:life_sciences_empirica_signal:*:*:*:*:*:*:*:*",
"versionEndIncluding": "9.2.3",
"versionStartIncluding": "9.2.1",
"vulnerable": true
}
],
"negate": false,
"operator": "OR"
}
]
}
],
"descriptions": [
{
"lang": "en-US",
"value": "Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N)."
}
],
"metrics": [
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "NETWORK",
"availabilityImpact": "NONE",
"baseScore": 8.5,
"baseSeverity": "HIGH",
"confidentialityImpact": "LOW",
"integrityImpact": "HIGH",
"privilegesRequired": "LOW",
"scope": "CHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N",
"version": "3.1"
}
}
],
"problemTypes": [
{
"descriptions": [
{
"description": "Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.",
"lang": "en-US"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2026-04-21T20:34:58.883Z",
"orgId": "43595867-4340-4103-b7a2-9a5208d29a85",
"shortName": "oracle"
},
"references": [
{
"name": "Oracle Advisory",
"tags": [
"vendor-advisory"
],
"url": "https://www.oracle.com/security-alerts/cpuapr2026.html"
}
]
}
},
"cveMetadata": {
"assignerOrgId": "43595867-4340-4103-b7a2-9a5208d29a85",
"assignerShortName": "oracle",
"cveId": "CVE-2026-21997",
"datePublished": "2026-04-21T20:34:58.883Z",
"dateReserved": "2026-01-05T18:07:34.723Z",
"dateUpdated": "2026-04-22T14:03:00.137Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.2"
}